SUTURE, MAXON GRN 0 27″ T-12 (36/BX)
| Item Id | 166053 |
| Manufacturer # | 8886626761 |
| Brand | Maxon™ |
| Manufacturer | Covidien |
| Country of Origin | Unknown |
| Application | Absorbable Suture with Needle |
| Coating | Uncoated |
| Is_Active_Vendor | Y |
| Is_DSCSA | N |
| Is_Discontinued | N |
| Is_Medical_Device | Y |
| Lot_Tracking_Flag | N |
| Needle 1 Code | GS -21 |
| Needle Length | 37 mm |
| Needle Length Range | 20.1 to 40 mm |
| Needle Material | Alloy Needle |
| Needle Shape | 1/2 Circle |
| Needle Type | Taper Point Needle |
| Number of Needles | 1-Needle |
| On_Allocation | N |
| Supplier_ID | 487778 |
| Suture Color | Green |
| Suture Length | 30 Inch |
| Suture Length Range | 20.1 to 40 in |
| Suture Material | Polyglyconate |
| Suture Material Range | Dyed Synthetic |
| Suture Size | Size 0 |
| Suture Type | Monofilament |
| UNSPSC Code | 42312201 |
Features
- MAXON™ and MAXON™ CV synthetic absorbable sutures are prepared from polyglyconate, a copolymer of glycolic acid and trimethylene carbonate
- MAXON™ and MAXON™ CV synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular surgery
- MAXON™ and MAXON™ CV synthetic absorbable sutures are not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissues
- MAXON™ sutures retain approximately 75% of initial tensile strength at two weeks, 65% of at three weeks and 50% at four weeks post-implant
- Absorption of MAXON™ sutures is minimal until about 60 days after implant and is essentially complete within six months
- This product is required to be reported under California Proposition 65
